Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
250 participants
INTERVENTIONAL
2022-09-21
2025-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of Phage Therapy for Treatment of a Periprosthetic Joint Infection
NCT06827041
Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI)
NCT05269134
Bacteriophage Therapy in First Time Chronic Prosthetic Joint Infections
NCT05269121
Phage Therapy for the Treatment of a Chronic Enterococcus Faecium Periprosthetic Joint Infection
NCT06942624
Evaluation of a mNGS Workflow for Infection Diagnosis Using Oxford Nanopore Sequencing.
NCT04864873
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Culture-based treatment
Culture-based treatment
Medications to treat prosthetic joint infection will be chosen based on results of traditional cultures alone
Next Generation Sequencing (NGS) with Culture-based treatment
Next Generation Sequencing (NGS) with Culture
Medications to treat prosthetic joint infection will be chosen based results of NGS and culture
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Culture-based treatment
Medications to treat prosthetic joint infection will be chosen based on results of traditional cultures alone
Next Generation Sequencing (NGS) with Culture
Medications to treat prosthetic joint infection will be chosen based results of NGS and culture
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Undergoing single stage revision or 1st stage resection arthroplasty/spacer placement for PJI (ICM-positive) of the hip or knee
* Written informed consent
Exclusion Criteria
* Megaprosthesis
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Center for Innovation and Research Organization
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tiffany Morrison
Role: STUDY_DIRECTOR
Center for Innovation and Research Organization
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Southern California
Los Angeles, California, United States
Cleveland Clinic Florida
Weston, Florida, United States
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States
Columbia University
New York, New York, United States
University of Rochester
Rochester, New York, United States
Northwell Health
Staten Island, New York, United States
Cleveland Clinic Ohio
Cleveland, Ohio, United States
Rothman Orthopaedic Institute
Philadelphia, Pennsylvania, United States
University of Utah
Salt Lake City, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022NGSOutcomes
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.